Biotechnology News

Tue, 2014-04-08 14:01

WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, a leading developer of precision vascular robotics, today announced that Tal Wenderow, Co-founder and EVP of Product & Business Development of Corindus, will present at the upcoming...

Tue, 2014-04-08 14:01

SAN CLEMENTE, Calif. & SHANGHAI--(BUSINESS WIRE)--ReFlow Medical enters into a partnership with leading Chinese medical device company

Tue, 2014-04-08 10:01

PITTSBURGH--(BUSINESS WIRE)--Positive clinical trial results of a topical botulinum toxin formulation for overactive bladder (OAB) are presented.

Tue, 2014-04-08 10:01

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that it will receive milestone payments from Takeda Pharmaceutical Company Limited (Takeda) totaling $6 million as a result of achieving the first commercial...

Tue, 2014-04-08 10:01

BERKELEY HEIGHTS, N.J.--(BUSINESS WIRE)--Edge Therapeutics today announced the appointment and promotion of key executives to its senior management team to strengthen the Company’s leadership.

Tue, 2014-04-08 10:01

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announces the approval of the generic equivalent to Lovaza® (Omega-3-Acid Ethyl Esters Capsules, USP), in the United States. Teva believes it is first-to-file and thus...

Tue, 2014-04-08 10:01

PITTSBURGH--(BUSINESS WIRE)--CardiacAssist received a Class 4 medical device license from Health Canada for the TandemHeart System to provide up to 10 days of percutaneous circulatory support for patients in cardiac distress.

Tue, 2014-04-08 10:01

TEWKSBURY, Mass.--(BUSINESS WIRE)--Mitralign Completes Enrollment in EU Study for its Novel Catheter-based Valve Repair Device

Tue, 2014-04-08 10:01

LEXINGTON, Mass.--(BUSINESS WIRE)--N-of-One announced an agreement with Dartmouth-Hitchcock Medical Center in Lebanon, NH to provide clinical interpretation for Dartmouth-Hitchcock’s Next-Generation Sequencing tests.

Tue, 2014-04-08 10:01

BERLIN--(BUSINESS WIRE)--NOXXON Pharma announced today that their anti-Hepcidin Spiegelmer® Lexaptepid Pegol (NOX-H94) increases hemoglobin in subset of anemic patients in pilot phase IIa study.

Tue, 2014-04-08 10:01

NORTH ANDOVER, Mass.--(BUSINESS WIRE)--MindChild Medical, Inc. today announced that the MERIDIAN Non-Invasive Fetal Heart Rate Monitor successfully completed it’s 1,000th non-invasive fetal heart monitoring session. Five separate health care...

Tue, 2014-04-08 10:01

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex to Showcase Urological Products at the European Association of Urology's 29th Annual Congress

Tue, 2014-04-08 10:01

SAN JOSE, Calif.--(BUSINESS WIRE)--HighTech Business Decisions publishes new report on the mammalian cell culture media market for biopharmaceutical production.

Tue, 2014-04-08 10:01

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today announced positive topline results from a randomized, double-blind, placebo-controlled phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia. Patients treated...

Tue, 2014-04-08 10:01

BRISBANE & THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc., a drug development company with a focus on innovative therapies for patients with debilitating diseases, announced today that it has strengthened its board of...

Tue, 2014-04-08 10:01

TOKYO--(BUSINESS WIRE)--PeptiDream Inc., a public Tokyo-based biopharmaceutical company (“PeptiDream”)( TOKYO:4587) announced today, in collaboration with The Tokyo Metropolitan Institute of Medical Science (“Tokyo Metropolitan Institute”) the...

Tue, 2014-04-08 10:01

INGELHEIM, Germany--(BUSINESS WIRE)--For media outside of the U.S., the UK & Canada only Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa® (dabigatran etexilate) for the treatment of...

Mon, 2014-04-07 23:00

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, PhD will present at...

Mon, 2014-04-07 18:00

NEW YORK--(BUSINESS WIRE)--Deerfield Management Company announced today that it has launched Deerfield Private Design Fund III, an investment fund designed to provide flexible private financing to healthcare companies. The fund has approximately...

Mon, 2014-04-07 18:00

PARSIPPANY, N.J.--(BUSINESS WIRE)--Pacira Pharmaceuticals Announces Proposed Public Offering of Common Stock

Mon, 2014-04-07 18:00

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River announces the date of its first-quarter 2014 earnings release and conference call. The conference call will be held on May 1, 2014 at 9:00am EDT.

Mon, 2014-04-07 18:00

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today presented new preclinical data demonstrating the ability of its Toll-like receptor (TLR) antagonist, IMO-8400, to inhibit the survival and proliferation of B-cell...

Mon, 2014-04-07 18:00

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND presents clinical data demonstrating differentiating attributes of BIND-014 administered with a weekly dosing schedule which may enable increased dose intensity and enhanced therapeutic efficacy

Mon, 2014-04-07 18:00

CINCINNATI--(BUSINESS WIRE)--Aerpio Therapeutics' President and CEO, Joseph Gardner, PhD, will present at the 13th Annual Needham Healthcare Conference on Wednesday, April 9, 2014, at 9:20 am ET.

Mon, 2014-04-07 18:00

TEL AVIV, Israel--(BUSINESS WIRE)--StoreDot demos new battery technology that will allow you to charge your smartphone in 30 seconds.

Mon, 2014-04-07 18:00

WASHINGTON--(BUSINESS WIRE)--Optegra, the specialist eye hospital group, announces today that it is further investing in the advanced LENSAR(TM) Femtosecond Cataract Laser distributed by Topcon. Optegra will become the first national eye care...

Mon, 2014-04-07 18:00

BOSTON--(BUSINESS WIRE)--MDGBoston announced today that it will sponsor a symposium on Wednesday, June 11, 2014: “The Year of the Brain: Advances in Imaging, Diagnostics and Therapeutic Delivery,” from 3:30—8:00 p.m. at Foley Hoag Law Offices,...

Mon, 2014-04-07 18:00

LOS ANGELES--(BUSINESS WIRE)--Positive data from Puma Biotechnology's Phase II I-SPY 2 TRIAL of PB272 for the neoadjuvant treatment of breast cancer was presented at the AACR 2014 Annual Meeting.

Mon, 2014-04-07 18:00

ST. PAUL, Minn.--(BUSINESS WIRE)--Saint Paul-based gene-editing innovator Surrogen announced its entry into the marketplace, further advancing a leadership position in biomedicine and replicable human disease models. The announcement is being...

Mon, 2014-04-07 13:01

GAITHERSBURG, Md.--(BUSINESS WIRE)--Smithers Avanza announced that Dr. Michael Dorato has been appointed as Executive Vice President, Smithers Avanza Development Services.

Mon, 2014-04-07 13:01

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) today highlighted research related to its antibody-drug conjugate (ADC) programs and technology in more than 15 presentations at the 105th Annual Meeting of the American...

Mon, 2014-04-07 13:01

MUNICH--(BUSINESS WIRE)--Definiens announced today that it has signed an agreement with INSERM Transfert to sponsor the worldwide consortium for the validation of the Immunoscore, a new approach to cancer therapy.

Mon, 2014-04-07 13:01

WASHINGTON--(BUSINESS WIRE)--Executives from consumer product and renewable chemical companies will present recent achievements in synthetic biology and genomics research at the BIO World Congress on Industrial Biotechnology.

Mon, 2014-04-07 13:01

TORONTO--(BUSINESS WIRE)--The second Canadian Live Below the Line campaign, presented by the Micronutrient Initiative, kicks off in three weeks. From April 28 to May 2, 2014, participants will spend only $1.75 per day on all food and drink, the...

Mon, 2014-04-07 13:01

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ: CGEN) issued the following statement today. In recent days newspapers in Israel have reported that the Israel Securities Authority (“ISA”) is investigating Mr. Aryeh Czaczkes Axselbrad,...

Mon, 2014-04-07 13:01

CAMBRIDGE, Mass.--(BUSINESS WIRE)--PatientsLikeMe announces a 5-year agreement with Genentech to explore use of PatientsLikeMe’s network to develop innovative ways of researching patients’ real-world experiences.

Mon, 2014-04-07 13:01

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea appoints Jonathan Poole to the position of chief financial officer.

Mon, 2014-04-07 13:01

EAGAN, Minn.--(BUSINESS WIRE)--Research further elucidating the role of the biomarker for Biothera’s cancer immunotherapy Imprime PGG® will be presented today at the American Association for Cancer Research’s (AACR) annual meeting in San Diego....

Mon, 2014-04-07 13:01

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Announces Once-Daily Aptiom® (eslicarbazepine acetate) for the Adjunctive Treatment of Partial-Onset Seizures Now Available in U.S. Pharmacies

Mon, 2014-04-07 13:01

SAN FRANCISCO--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK), a leading North American healthcare services and information technology company, announced today that the results of the initial acceptance period of the voluntary public takeover...

Mon, 2014-04-07 13:01

SUNNYVALE, Calif.--(BUSINESS WIRE)--"Icon is on the threshold of an important new growth phase and I expect Icon's Verisome technology to drive a transformational change in ophthalmic pharmaceuticals," said David S. Tierney

Mon, 2014-04-07 13:01

SAN DIEGO--(BUSINESS WIRE)--Knowledge of driver mutations is essential to research and development in the pharmaceutical industry for the identification of novel populations and discovery of new cancer drug targets. Gene over-expression is one of...

Mon, 2014-04-07 13:01

SALT LAKE CITY--(BUSINESS WIRE)--Tolero Pharmaceuticals, Inc., a clinical-stage company developing treatments for serious hematological diseases, today announced that a poster related to its development program alvocidib, a potent cyclin-...